(NASDAQ: ICLR) Icon's forecast annual revenue growth rate of 1.01% is not forecast to beat the US Diagnostics & Research industry's average forecast revenue growth rate of 5.11%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 10.4%.
Icon's revenue in 2025 is $8,192,622,000.On average, 6 Wall Street analysts forecast ICLR's revenue for 2025 to be $632,341,712,074, with the lowest ICLR revenue forecast at $626,962,061,677, and the highest ICLR revenue forecast at $640,116,335,561. On average, 6 Wall Street analysts forecast ICLR's revenue for 2026 to be $645,008,552,235, with the lowest ICLR revenue forecast at $631,391,160,691, and the highest ICLR revenue forecast at $665,988,306,727.
In 2027, ICLR is forecast to generate $674,909,917,228 in revenue, with the lowest revenue forecast at $652,687,580,227 and the highest revenue forecast at $707,458,315,918.